Central Trust Company’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Central Trust Company’s Portfolio IBDX Stock Details IBDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.06M	Buy	81,586 +42,239	+107%	+$1.08M	0.04%	249
2025 Q4	$1M	Buy	39,347 +34,832	+771%	+$891K	0.02%	339
2025 Q3	$116K	Buy	4,515 +1,593	+55%	+$40.4K	﹤0.01%	671
2025 Q2	$73.9K	Sell	2,922 -269	-8%	-$6.67K	﹤0.01%	727
2025 Q1	$79.7K	Buy	3,191 +6	+0.2%	+$148	﹤0.01%	700
2024 Q4	$78.3K	Buy	3,185 +2,199	+223%	+$55K	﹤0.01%	703
2024 Q3	$25.4K	Sell	986 -249	-20%	-$6.29K	﹤0.01%	910
2024 Q2	$30.3K	Buy	1,235 +25	+2%	+$611	﹤0.01%	870
2024 Q1	$30K	Sell	1,210 -591	-33%	-$14.6K	﹤0.01%	899
2023 Q4	$45.4K	Buy	1,801 +101	+6%	+$2.41K	﹤0.01%	810
2023 Q3	$39.9K	Buy	1,700 +1,362	+403%	+$32.9K	﹤0.01%	810
2023 Q2	$8.32K	Buy	+338	New	+$8.37K	﹤0.01%	1048

Other funds holding IBDX

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

SIC

Sigma Investment Counselors Northville, Michigan $1.89B AUM 14.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Klingman & Associates New York $2.09B AUM 16.49% 1-Year Est. Return

Central Trust Company's IBDX Position: Q1 2026 in Review

Central Trust Company increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 107% in Q1 2026, buying an estimated $1.08M and bringing the position to 81,586 shares worth $2.06M. The position accounts for 0.04% of the portfolio, ranked #249.

Central Trust Company first reported a position in IBDX in Q2 2023 and has held it in 12 quarters since. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.

Central Trust Company held 81,586 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $2.06M as of Q1 2026.
Central Trust Company bought 42,239 iShares iBonds Dec 2032 Term Corporate ETF shares in Q1 2026, an estimated $1.08M.
iShares iBonds Dec 2032 Term Corporate ETF made up 0.04% of Central Trust Company's portfolio in Q1 2026, its #249 holding.
Central Trust Company first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2023 and has held it in 12 quarters since.
221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.